By Staff Reporters
***
***
After last week’s sharp decline, the S&P is down 5.7% so far in April and is on track for its worst monthly drop since March 2020, when the spreading COVID-19 pandemic blasted stocks.
Related: https://medicalexecutivepost.com/2021/11/28/living-with-higher-stock-market-volatility/
And, battered U.S. stocks are facing a potentially painful stretch in the weeks ahead as hawkish Federal Reserve policy, rising bond yields, geopolitical uncertainty and the corporate earnings season fuel investor unease. For example:
REPORTING COMPANIES:
Monday: Germany business climate; Earnings from PepsiCo and Whirlpool
Tuesday: US consumer confidence; Earnings from 3M, General Electric, JetBlue, UPS, Warner Bros. Discovery, Alphabet, General Motors, Mondelez, Microsoft and Visa
Wednesday: Earnings from Boeing, Harley-Davidson, Kraft Heinz, Spotify, Ford Motor, Mattel, Meta and PayPal
Thursday: Bank of Japan policy decision; US first quarter GDP; Earnings from Caterpillar, Altria, Domino’s Pizza, Mastercard, Twitter, Amazon, Apple, Intel, Roku and Robinhood
Friday: Europe first quarter GDP and inflation data; US personal income and spending data; PCE Price Index; Earnings from ExxonMobil and Chevron
One measure of investor anxiety, the CBOE Volatility Index, known as Wall Street’s fear gauge, on Friday notched its largest one-day gain in about five months to close at a five-week high of 28.21.
Related: https://medicalexecutivepost.com/2022/01/19/what-up-vix/
***
COMMENTS APPRECIATED
Thank You
***
****
Filed under: Alerts Sign-Up, Glossary Terms, Investing | Tagged: CBOE, Covid-19, Federal Reserve, pandemic, S&P, Volatility Index | 1 Comment »